Virtus ETF Advisers LLC Ligand Pharmaceuticals Inc Transaction History
Virtus ETF Advisers LLC
- $196 Million
- Q2 2024
A detailed history of Virtus ETF Advisers LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 4,049 shares of LGND stock, worth $394,251. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,049
Previous 5,628
28.06%
Holding current value
$394,251
Previous $411,000
17.03%
% of portfolio
0.17%
Previous 0.22%
Shares
27 transactions
Others Institutions Holding LGND
# of Institutions
247Shares Held
17.5MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$280 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$188 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$98.2 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$94.1 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX709KShares$69 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.64B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...